Keywords
E-Cigarette Vapor
Lung Injury
Vaping
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To review the use of e-cigarette and its relationship with lung disease. Literature review: The association between potential lung damage and e-cigarette use have shown that there is increased susceptibility to extracellular neutrophil trapping. The problem, therefore, lies in the fact that extensive degranulation characterizes some lung diseases involving inflammation, such as severe asthma and chronic obstructive pulmonary disease. The term EVALI refers to electronic cigarette-induced lung damage. Epidemiological data have shown that the manifested damage seriously compromises lung function and can lead to death. The highest risk was observed among assiduous smokers. In reporting the main acute complications associated with EVALI, pneumothorax and pneumomediastinum are found. Among the main patterns of pneumopathies described, pneumonia, diffuse alveolar damage, giant cell interstitial pneumonia, and hypersensitivity pneumonitis also stand out. Final considerations: The main lung diseases associated with the use of electronic cigarettes are pneumopathies such as pneumonia, giant cell interstitial pneumonia, hypersensitivity pneumonitis, pneumothorax and pneumomediastinum. Moreover, it is necessary to implement more effective health education policies in order to reduce the proportion of users and consequently hospitalizations, complications, and deaths.
References
ANTONIEWICKZ L, et al. Acute Effects of Electronic Cigarette Inhalation on the Vasculature and the Conducting Airways. Cardiovascular Toxicology, 2019; 19: 441-450.
BAGLEV DP, et al. Clínical presentation, a treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study. The Lancet, 2019; 394(10214): 2073-2083.
BANKS E, et al. Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence. and systematic review of the global evidence. National Centre for Epidemiology and Population Health, 2023; 218(6): 267-275.
BELLO S. Daño pulmonar asociado al uso de cigarrillos electrónicos-vapeadores. Revista chilena de enfermedades respiratorias, 2020; 36(2): 115-121.
BERTONI N, et al. Prevalência de uso de dispositivos eletrônicos para fumar e de uso de narguilé no Brasil: para onde estamos caminhando. Revista Brasileira de Epidemiologia, 2021; 24(2): e21007.
CAO DJ, et al. Review of health consequences of electronic cigarettes and the outbreak of electronic cigarette, or vaping, product use-associated lung injury. Journal of medical toxicology, 2020; 16(3): 295-310.
CECCHINI MJ, et al. E-cigarette or vaping product use-associated lung injury: a review for pathologists. Archives of Pathology & Laboratory Medicine, 2020; 144(12): 1490-1500.
CHAUMONT M, et al. Fourth generation e-cigarette vaping induces transient lung inflammation and gas exchange disturbances: results from two randomized clinical trials. American journal of physiology. Lung cellular and molecular physiology, 2019; 316(5): 705–719.
CHAABAN, T. Acute eosinophilic pneumonia associated with non-cigarrete smoking produtcs: a systematic review. Advances in Respiratory Medicine, 2020; 88(2): 142-146.
FELDMAN R, et al. Compiling Evidence for EVALI: A Scoping Review of In Vivo Pulmonary Effects After Inhaling Vitamin E or Vitamin E Acetate. Journal of Medical Toxicology, 2021; 17: 278–288.
GHOSH A, et al. Chronic E-Cigarette Exposure Alters the Human Bronchial Epithelial Proteome. American Journal of Respiratory and Critical Care Medicine, 2018; 198(1): 67–76.
GONSALVES C, et al. Diagnosis and Acute Management of E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI) in the Pediatric Population: A Systematic Review. The Journal of Pediatrics, 2020; 6(7): e1000097.
KLIGERMAN S, et al. Radiologic, Pathologic, Clinical, and Physiologic Findings of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI). Radiology, 2020; 294: 491–505.
JONAS AM e RAJ R. Vaping-related acute parenchymal lung injury: A systematic review. Chest, 2020; 158(4): 1555–1565.
MADO H, et al. The vaping product use associated lung injury: is this a new pulmonares disease entity?. Rev Environ Health, 2021; 36(2): 145–157.
MARTIN M, et al. A relação entre a utilização de cigarros eletrônicos e doenças pulmonares: uma revisão integrativa. Research, Society and Development, 2022; 11(1): e13211125030.
MATOS M, et al. Diagnósticos diferenciais de opacidade em vidro fosco aguda na tomografia computadorizada de tórax: ensaio pictórico. Einstein (São Paulo), 2021; 19: eRW5772.
REIDEL B, et al. E-Cigarette Use Causes a Unique Innate Immune Response in the Lung, Involving Increased Neutrophilic Activation and Altered Mucin Secretion. American Journal of Respiratory and Critical Care Medicine, 2018; 197(4): 492–501.
SREEDHARAN S, et al. Radiological findings of e-cigarette or vaping product use associated lung injury: A systematic review. Heart Lung, 2021; 50: 736-741.
TZORTZI A, et al. A Systematic Literature Review of E-Cigarette-Releated Illness and Injury: Not Just for the Respirologist. Enviromental Research and Public Health, 2020; 17(7): 2248.
XANTUS G, et al. The role of vitamin E acetate (VEA) and its derivatives in the vaping associated lung injury: systematic review of evidence. Critical Reviews in Toxicology, 2021; 51(1): 15-23.
WHITE A, et al. Risk assessment of inhaled diacetyl from electronic cigarette use among teens and adults. Science of the Total Environment, 2021; 772: 145486.